tiprankstipranks
InnoCare Pharma Ltd. (HK:9969)
:9969
Hong Kong Market
9969
InnoCare Pharma Ltd.
RESEARCH TOOLSreports

InnoCare Pharma Ltd. (9969) Ratios

2 Followers

InnoCare Pharma Ltd. Ratios

HK:9969's free cash flow for Q4 2025 was ¥0.93. For the 2025 fiscal year, HK:9969's free cash flow was decreased by ¥ and operating cash flow was ¥0.53. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.83 5.83 7.37 4.19 4.48
Quick Ratio
 5.71 5.71 7.28 4.13 4.45
Cash Ratio
 5.11 5.11 5.86 3.93 4.19
Solvency Ratio
 0.26 0.27 -0.14 -0.20 -0.31
Operating Cash Flow Ratio
 0.11 0.14 -0.34 -0.32 -0.27
Short-Term Operating Cash Flow Coverage
 0.46 0.63 -1.89 -0.54 -0.47
Net Current Asset Value
¥ 5.28B¥ 5.28B¥ 5.16B¥ 6.03B¥ 6.62B
Leverage Ratios
Debt-to-Assets Ratio
 0.15 0.15 0.14 0.14 0.12
Debt-to-Equity Ratio
 0.21 0.21 0.19 0.19 0.16
Debt-to-Capital Ratio
 0.17 0.17 0.16 0.16 0.14
Long-Term Debt-to-Capital Ratio
 0.14 0.14 0.13 <0.01 0.04
Financial Leverage Ratio
 1.40 1.40 1.40 1.39 1.36
Debt Service Coverage Ratio
 1.64 1.47 -2.04 -0.40 -0.65
Interest Coverage Ratio
 20.26 8.21 -15.56 -18.59 -45.20
Debt to Market Cap
 0.08 0.08 0.12 0.12 0.08
Interest Debt Per Share
 0.93 0.95 0.77 0.81 0.86
Net Debt to EBITDA
 -9.51 -9.83 10.68 13.31 9.21
Profitability Margins
Gross Profit Margin
90.88%87.59%86.29%82.61%77.07%
EBIT Margin
21.61%19.18%-51.66%-82.48%-140.18%
EBITDA Margin
24.39%24.20%-45.91%-69.94%-129.24%
Operating Profit Margin
22.98%19.18%-52.09%-88.17%-123.19%
Pretax Profit Margin
27.38%27.80%-44.84%-87.23%-142.90%
Net Profit Margin
26.84%27.24%-43.65%-85.47%-141.76%
Continuous Operations Profit Margin
26.89%27.31%-44.86%-87.42%-142.90%
Net Income Per EBT
98.02%97.98%97.36%97.99%99.20%
EBT Per EBIT
119.13%144.98%86.08%98.93%116.01%
Return on Assets (ROA)
5.84%5.78%-4.68%-6.36%-8.59%
Return on Equity (ROE)
9.08%8.10%-6.55%-8.83%-11.67%
Return on Capital Employed (ROCE)
5.73%4.67%-6.30%-8.32%-9.34%
Return on Invested Capital (ROIC)
5.45%4.43%-6.13%-7.16%-7.94%
Return on Tangible Assets
5.98%5.92%-4.70%-6.39%-8.63%
Earnings Yield
2.63%3.21%-4.53%-5.93%-4.98%
Efficiency Ratios
Receivables Turnover
 4.64 4.53 2.88 4.59M 3.52
Payables Turnover
 1.17 1.55 1.08 0.95 1.21
Inventory Turnover
 1.32 1.75 1.45 1.08 2.20
Fixed Asset Turnover
 3.01 2.94 0.95 0.68 0.66
Asset Turnover
 0.22 0.21 0.11 0.07 0.06
Working Capital Turnover Ratio
 0.35 0.34 0.15 0.11 0.09
Cash Conversion Cycle
 43.21 53.94 40.48 -44.93 -32.03
Days of Sales Outstanding
 78.60 80.61 126.92 <0.01 103.57
Days of Inventory Outstanding
 276.76 208.55 251.99 338.46 166.27
Days of Payables Outstanding
 312.16 235.22 338.43 383.39 301.87
Operating Cycle
 355.37 289.16 378.91 338.46 269.84
Cash Flow Ratios
Operating Cash Flow Per Share
 0.08 0.11 -0.22 -0.39 -0.38
Free Cash Flow Per Share
 0.04 0.07 -0.26 -0.54 -0.63
CapEx Per Share
 0.04 0.04 0.05 0.15 0.25
Free Cash Flow to Operating Cash Flow
 0.52 0.66 1.21 1.38 1.65
Dividend Paid and CapEx Coverage Ratio
 1.68 2.91 -0.83 -2.62 -1.51
Capital Expenditure Coverage Ratio
 2.08 2.91 -4.67 -2.64 -1.53
Operating Cash Flow Coverage Ratio
 0.09 0.12 -0.29 -0.50 -0.45
Operating Cash Flow to Sales Ratio
 0.06 0.09 -0.36 -0.91 -0.90
Free Cash Flow Yield
0.37%0.67%-4.57%-8.69%-5.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 38.00 31.11 -22.06 -16.87 -20.10
Price-to-Sales (P/S) Ratio
 8.64 8.47 9.63 14.42 28.49
Price-to-Book (P/B) Ratio
 3.11 2.52 1.45 1.49 2.35
Price-to-Free Cash Flow (P/FCF) Ratio
 269.49 148.84 -21.90 -11.50 -19.04
Price-to-Operating Cash Flow Ratio
 164.74 97.76 -26.59 -15.87 -31.51
Price-to-Earnings Growth (PEG) Ratio
 0.11 -0.13 0.74 0.44 -0.02
Price-to-Fair Value
 3.11 2.52 1.45 1.49 2.35
Enterprise Value Multiple
 25.94 25.19 -10.29 -7.31 -12.84
Enterprise Value
 14.91B 14.00B 4.77B 3.78B 10.37B
EV to EBITDA
 25.94 25.19 -10.29 -7.31 -12.84
EV to Sales
 6.33 6.10 4.72 5.11 16.59
EV to Free Cash Flow
 197.21 107.07 -10.74 -4.08 -11.09
EV to Operating Cash Flow
 102.19 70.32 -13.04 -5.62 -18.34
Tangible Book Value Per Share
 4.42 4.42 3.97 4.18 5.14
Shareholders’ Equity Per Share
 4.39 4.39 3.98 4.19 5.13
Tax and Other Ratios
Effective Tax Rate
 0.02 0.02 >-0.01 >-0.01 0.02
Revenue Per Share
 1.34 1.30 0.60 0.43 0.42
Net Income Per Share
 0.36 0.36 -0.26 -0.37 -0.60
Tax Burden
 0.98 0.98 0.97 0.98 0.99
Interest Burden
 1.27 1.45 0.87 1.06 1.02
Research & Development to Revenue
 0.39 0.37 0.81 1.02 1.02
SG&A to Revenue
 0.32 0.31 0.31 0.07 0.08
Stock-Based Compensation to Revenue
 0.01 0.00 -0.01 0.09 0.21
Income Quality
 0.23 0.32 0.81 1.04 0.63
Currency in CNY